The short answer
BPC-157 carries CAS Registry Number 137525-51-0, PubChem CID 9941957 and UNII 8ED8NXK95P, with molecular formula C62H98N16O22 and molecular weight 1419.5 Da. Unlike TB-500 or GHK-Cu, one name maps cleanly to one compound.
Key facts
- CAS Registry Number
- 137525-51-0
- PubChem CID
- 9941957
- UNII
- 8ED8NXK95P
- Molecular formula
- C62H98N16O22
- Molecular weight
- 1419.5 Da
- Development codes
- PL-14736, PLD-116, PL-10
- Also indexed as
- Bepecin
A category without an identity problem
This matters because the neighbouring categories have one. TB-500 shares a name with a protein 5.6 times its mass; GHK-Cu is routinely quoted with the free peptide's molecular weight. BPC-157 has one CAS number, one PubChem record, one molecular weight and one sequence, and they agree with each other. The identifier is unambiguous.
The development codes
PL-14736 is the code under which BPC-157 entered clinical development for inflammatory bowel disease, and it is the term the clinical literature uses. PLD-116 and PL-10 also appear, along with the name Bepecin. Searching the codes surfaces records the compound name misses; the clinical work in particular is indexed under PL-14736.
Research material referenced
BPC-157 5mg, third-party HPLC tested
Confirming identity
Mass spectrometry against 1419.5 Da for C62H98N16O22. The sequence contains no cysteine and no methionine, so neither disulfide species nor the +16 Da oxidation satellite should appear; their presence indicates something other than the stated compound.
Confirming purity
Reverse-phase HPLC against truncated and deletion sequences. Fifteen residues is a moderate synthesis, longer than the heptapeptides in neighbouring categories and with correspondingly more opportunity for incomplete coupling. The four prolines are relevant here too: proline coupling is sterically hindered and is a recognised difficult step in solid-phase synthesis, so a peptide with four of them warrants attention to the purity figure.
The acetate question
Synthetic peptides are typically supplied as salts, and the counter-ion contributes to gross vial weight. Net peptide content is lower than the powder weighs, and a certificate should state the two separately. This is general rather than specific to BPC-157, but it applies here as everywhere.
Frequently asked questions
What is BPC-157's CAS number?
137525-51-0, corresponding to PubChem CID 9941957 at 1419.5 Da. The identifiers agree with each other, which is not true of every research peptide.
What is PL-14736?
The development code under which BPC-157 entered clinical trials for inflammatory bowel disease. The clinical literature is indexed under it.
Why does proline content matter for purity?
Proline coupling is sterically hindered and is a recognised difficult step in solid-phase synthesis. Four prolines in fifteen residues deserve attention when reading a purity figure.
Continue researching
Peer-reviewed guides, comparators and matched reference materials.
Primary sources & clinical trials
Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.
- PubChemPubChem · BPC-157 (CID 9941957)pubchem.ncbi.nlm.nih.gov
- PubMedSikiric P et al., BPC 157 in trials for inflammatory bowel disease. Inflammopharmacology 2006 (PMID 17186181)pubmed.ncbi.nlm.nih.gov
- PubMedSikiric P et al., Fistulas Healing: Stable Gastric Pentadecapeptide BPC 157 Therapy. Curr Pharm Des 2020 (PMID 32329684)pubmed.ncbi.nlm.nih.gov
- PubMedKrivic A et al., Achilles detachment in rat and stable gastric pentadecapeptide BPC 157. J Orthop Res 2006 (PMID 16583442)pubmed.ncbi.nlm.nih.gov
- PubMedCerovecki T et al., Pentadecapeptide BPC 157 improves ligament healing in the rat. J Orthop Res 2010 (PMID 20225319)pubmed.ncbi.nlm.nih.gov
- PubMedSeiwerth S et al., BPC 157 and blood vessels. Curr Pharm Des 2014 (PMID 23782145)pubmed.ncbi.nlm.nih.gov
- GuidelineGoogle: Creating helpful, reliable, people-first contentdevelopers.google.com
Browse the wider literature
Live database searches, not fixed citations. Results change as new work is indexed.
Written and reviewed by
William Heath · Editor, UK Peptides research library
William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.
More BPC-157 (Pentadecapeptide) articles
- BPC-157 Molecular Weight: 1419.5 Da1419.5 Da for C62H98N16O22, verified against PubChem CID 9941957. Why this figure is stable across sources when others in the field are not.
- BPC-157 vs TB-500 ComparedDifferent origins, sizes, mechanisms and evidential positions. BPC-157 has registered clinical trials; TB-500's literature largely concerns its parent protein.
- BPC-157 Structure and SequenceGEPPPGKPADDAGLV: fifteen residues, four prolines, three glycines, no cysteine or methionine and no aromatic residue. What that composition implies.
- The Proline Problem in BPC-157 SynthesisFour prolines, three consecutive, make solid-phase synthesis meaningfully harder. Why proline coupling is a recognised difficult step, and what it costs purity.
- BPC-157 Molecular Structure and Physical Properties1419.5 Da, net negatively charged, highly water-soluble, conformationally mixed. The physical consequences of a proline- and glycine-rich fifteen-mer.